Stempoint Capital »

Autolus Therapeutics Plc spon ads shares owned by Stempoint Capital

Quarter-by-quarter ownership of Autolus Therapeutics Plc spon ads (AUTL) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Autolus Therapeutics Plc spon ads

Tip: Access up to 7 years of quarterly data

All positions including Autolus Therapeutics Plc spon ads held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Autolus Therapeutics Plc spon ads by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $9.5M 2.6M 3.63
2024-06-30 $9.3M 2.7M 3.48
2024-03-31 $21M 3.2M 6.38

More positions owned by Stempoint Capital

Syndax Pharmaceuticals (SNDX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Merus N V (MRUS)
Arcutis Biotherapeutics (ARQT)
Amicus Therapeutics (FOLD)
Applied Therapeutics (APLT)
Bristol Myers Squibb (BMY)
Crinetics Pharmaceuticals In (CRNX)
Biohaven (BHVN)
Praxis Precision Medicines I Com New (PRAX)
Autolus Therapeutics Spon Ads (AUTL)
Incyte Corporation (INCY)
Denali Therapeutics (DNLI)
Day One Biopharmaceuticals I (DAWN)

View all positions for Stempoint Capital

Top funds holding Autolus Therapeutics Plc spon ads

Syncona Portfolio
Blackstone Group
Deep Track Capital
Polygon Management
Armistice Capital
Frazier Life Sciences Management
Affinity Asset Advisors
BlackRock
BlackRock
T. Rowe Price Associates
Deerfield Management Company
Laurion Capital Management
Morgan Stanley
Dr. Jeffrey R. Jay, M.D.
Stempoint Capital

View all funds holding Autolus Therapeutics Plc spon ads